Afeng Yang

515 total citations
10 papers, 432 citations indexed

About

Afeng Yang is a scholar working on Biomedical Engineering, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Afeng Yang has authored 10 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 6 papers in Immunology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Afeng Yang's work include Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (5 papers) and Immune cells in cancer (3 papers). Afeng Yang is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (5 papers) and Immune cells in cancer (3 papers). Afeng Yang collaborates with scholars based in China, United Kingdom and United States. Afeng Yang's co-authors include Feng Lv, Xia Dong, Deling Kong, Jie Liang, Zhiyong Qian, Yun Bai, Dunwan Zhu, Deling Kong, Jie Liang and Tianjun Liu and has published in prestigious journals such as Biomaterials, Chemical Engineering Journal and ACS Applied Materials & Interfaces.

In The Last Decade

Afeng Yang

10 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afeng Yang China 9 291 187 134 118 63 10 432
Zijian Xiong China 9 268 0.9× 126 0.7× 173 1.3× 119 1.0× 68 1.1× 14 477
Xinchao Li China 13 286 1.0× 138 0.7× 144 1.1× 112 0.9× 35 0.6× 29 470
Jia Cai China 10 231 0.8× 85 0.5× 203 1.5× 178 1.5× 63 1.0× 20 538
Yuka Umeki Japan 10 209 0.7× 239 1.3× 376 2.8× 116 1.0× 62 1.0× 10 607
Kaiqing Yun China 9 173 0.6× 100 0.5× 84 0.6× 107 0.9× 42 0.7× 14 366
Lu Diao China 13 196 0.7× 194 1.0× 232 1.7× 86 0.7× 93 1.5× 26 561
Francesca Persano Italy 10 134 0.5× 115 0.6× 273 2.0× 156 1.3× 58 0.9× 15 524
Julia S. Caserto United States 10 186 0.6× 86 0.5× 73 0.5× 148 1.3× 46 0.7× 11 396
Se−Na Kim South Korea 11 127 0.4× 104 0.6× 187 1.4× 106 0.9× 59 0.9× 16 395
Jun‐Hyeok Han South Korea 13 272 0.9× 166 0.9× 202 1.5× 105 0.9× 100 1.6× 23 550

Countries citing papers authored by Afeng Yang

Since Specialization
Citations

This map shows the geographic impact of Afeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afeng Yang more than expected).

Fields of papers citing papers by Afeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afeng Yang. The network helps show where Afeng Yang may publish in the future.

Co-authorship network of co-authors of Afeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Afeng Yang. A scholar is included among the top collaborators of Afeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afeng Yang. Afeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yang, Afeng, Yun Bai, Dunwan Zhu, et al.. (2022). Hydrogel/nanoparticles-mediated cooperative combination of antiangiogenesis and immunotherapy. Acta Biomaterialia. 153. 124–138. 10 indexed citations
2.
Yang, Afeng, Yun Bai, Xia Dong, et al.. (2021). Hydrogel/nanoadjuvant-mediated combined cell vaccines for cancer immunotherapy. Acta Biomaterialia. 133. 257–267. 35 indexed citations
3.
Yang, Afeng, Xia Dong, Yun Bai, et al.. (2021). Doxorubicin/CpG self-assembled nanoparticles prodrug and dendritic cells co-laden hydrogel for cancer chemo-assisted immunotherapy. Chemical Engineering Journal. 416. 129192–129192. 30 indexed citations
4.
Dong, Xia, Afeng Yang, Yun Bai, Deling Kong, & Feng Lv. (2019). Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumor microenvironment for effective chemo-immunotherapy. Biomaterials. 230. 119659–119659. 87 indexed citations
5.
Dong, Xia, Jie Liang, Afeng Yang, et al.. (2019). Fluorescence imaging guided CpG nanoparticles-loaded IR820-hydrogel for synergistic photothermal immunotherapy. Biomaterials. 209. 111–125. 113 indexed citations
6.
Dong, Xia, Jie Liang, Afeng Yang, et al.. (2019). A Visible Codelivery Nanovaccine of Antigen and Adjuvant with Self-Carrier for Cancer Immunotherapy. ACS Applied Materials & Interfaces. 11(5). 4876–4888. 58 indexed citations
7.
Liang, Jie, Xia Dong, Afeng Yang, et al.. (2018). A dual fluorescent reverse targeting drug delivery system based on curcumin-loaded ovalbumin nanoparticles for allergy treatment. Nanomedicine Nanotechnology Biology and Medicine. 16. 56–68. 25 indexed citations
8.
Wei, Chang, Xia Dong, Yan Zhang, et al.. (2018). Simultaneous fluorescence imaging monitoring of the programmed release of dual drugs from a hydrogel-carbon nanotube delivery system. Sensors and Actuators B Chemical. 273. 264–275. 48 indexed citations
9.
Yang, Afeng, Xia Dong, Jie Liang, et al.. (2018). Photothermally triggered disassembly of a visible dual fluorescent poly(ethylene glycol)/α-cyclodextrin hydrogel. Soft Matter. 14(22). 4495–4504. 8 indexed citations
10.
Dong, Xia, Jie Liang, Afeng Yang, et al.. (2018). In Vivo Imaging Tracking and Immune Responses to Nanovaccines Involving Combined Antigen Nanoparticles with a Programmed Delivery. ACS Applied Materials & Interfaces. 10(26). 21861–21875. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026